* Lixisenatide as adlyxin to treat type 2 diabetes
commercial launch by Sanofi in U.S. is expected later in H2
The post BRIEF-Zealand Pharma: royalty revenue of DKK 6.4 mln in Q2 on sales of Lyxumia appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Lixisenatide as adlyxin to treat type 2 diabetes
commercial launch by Sanofi in U.S. is expected later in H2
The post BRIEF-Zealand Pharma: royalty revenue of DKK 6.4 mln in Q2 on sales of Lyxumia appeared first on NASDAQ.